For: | Zhao JG, Hu Y, Liao Q, Niu ZY, Zhao YP. Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer. World J Gastroenterol 2014; 20(19): 5875-5880 [PMID: 24914348 DOI: 10.3748/wjg.v20.i19.5875] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5875.htm |
Number | Citing Articles |
1 |
Yuki Sato, Daichi Fujimoto, Keiichiro Uehara, Ryoko Shimizu, Jiro Ito, Mariko Kogo, Shunsuke Teraoka, Ryoji Kato, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Hiroshi Hamakawa, Yutaka Takahashi, Yukihiro Imai, Keisuke Tomii. The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2897-6
|
2 |
Jack Power, George Larcos. 18‐Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma. ANZ Journal of Surgery 2023; 93(1-2): 145 doi: 10.1111/ans.18236
|
3 |
Cosimo Sperti, Alberto Friziero, Simone Serafini, Sergio Bissoli, Alberto Ponzoni, Andrea Grego, Emanuele Grego, Lucia Moletta. Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer. Journal of Clinical Medicine 2020; 9(7): 2169 doi: 10.3390/jcm9072169
|
4 |
Ananya Panda, Ishan Garg, Mark J. Truty, Timothy L. Kline, Matthew P. Johnson, Eric C. Ehman, Garima Suman, Deema A. Anaam, Bradley J. Kemp, Geoffrey B. Johnson, Thorvardur R. Halfdanarson, Sudhakar K. Venkatesh, Jeff L. Fidler, Ajit H. Goenka. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival. American Journal of Roentgenology 2021; 217(3): 730 doi: 10.2214/AJR.20.24567
|
5 |
Kyuseok Im, Niharika Kareddy, Vikas Satyananda, Victoria V. O’Connor. Is pancreatic adenosquamous carcinoma (PASC) a surgical disease? A large healthcare system review. Surgical Oncology Insight 2024; 1(4): 100102 doi: 10.1016/j.soi.2024.100102
|
6 |
Ye Chen, She-Gan Gao, Jian-Min Chen, Gong-Ping Wang, Zeng-Fang Wang, Bo Zhou, Can-Hui Jin, Yan-Tong Yang, Xiao-Shan Feng. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. Cell Biochemistry and Biophysics 2015; 71(3): 1287 doi: 10.1007/s12013-014-0345-2
|
7 |
William McGahan, Venkata Chikatamarla, Paul Thomas, David Cavallucci, Nicholas O'Rourke, Matthew Burge. High SUVmax on routine pre-operative FDG-PET predicts early recurrence in pancreatic and peri-ampullary cancer. HPB 2022; 24(8): 1387 doi: 10.1016/j.hpb.2022.01.005
|
8 |
G. C. Deng, Y. Lv, H. Yan, D. C. Sun, T. T. Qu, Y. T. Pan, Q. L. Han, G. H. Dai. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08943-w
|
9 |
Ranvijay Singh, Sunita Aggarwal, Abhishek Verma, Puja Sakhuja, Sudipta Nandi, Kamal Garg. Primary hepatoid adenocarcinoma of lung: A rare malignancy mimicking tuberculosis. Lung India 2023; 40(6): 537 doi: 10.4103/lungindia.lungindia_117_23
|
10 |
Lu Bai, Chi-Hua Guo, Yan Zhao, Jun-Gang Gao, Miao Li, Cong Shen, You-Min Guo, Xiao-Yi Duan. SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients. Oncology Reports 2017; 37(6): 3433 doi: 10.3892/or.2017.5631
|
11 |
Silvana T. Tivadar, Richard S. McIntosh, Jia Xin Chua, Robert Moss, Tina Parsons, Abed M. Zaitoun, Srinivasan Madhusudan, Lindy G. Durrant, Mireille Vankemmelbeke. Monoclonal Antibody Targeting Sialyl-di-Lewisa–Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential. Molecular Cancer Therapeutics 2020; 19(3): 790 doi: 10.1158/1535-7163.MCT-19-0221
|
12 |
Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan. Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211043030
|